These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 16166332)
1. Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer. Alvarado C; Beitel LK; Sircar K; Aprikian A; Trifiro M; Gottlieb B Cancer Res; 2005 Sep; 65(18):8514-8. PubMed ID: 16166332 [TBL] [Abstract][Full Text] [Related]
2. Somatic mosaicism of androgen receptor CAG repeats in colorectal carcinoma epithelial cells from men. Di Fabio F; Alvarado C; Gologan A; Youssef E; Voda L; Mitmaker E; Beitel LK; Gordon PH; Trifiro M J Surg Res; 2009 Jun; 154(1):38-44. PubMed ID: 19062046 [TBL] [Abstract][Full Text] [Related]
3. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637 [TBL] [Abstract][Full Text] [Related]
4. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study. Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493 [TBL] [Abstract][Full Text] [Related]
5. Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues. Sircar K; Gottlieb B; Alvarado C; Aprikian A; Beitel LK; Alam-Fahmy M; Begin L; Trifiro M Prostate Cancer Prostatic Dis; 2007; 10(4):360-8. PubMed ID: 17440439 [TBL] [Abstract][Full Text] [Related]
6. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987 [TBL] [Abstract][Full Text] [Related]
7. The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer. Lange EM; Chen H; Brierley K; Livermore H; Wojno KJ; Langefeld CD; Lange K; Cooney KA Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):439-42. PubMed ID: 10794490 [TBL] [Abstract][Full Text] [Related]
8. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population. Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049 [TBL] [Abstract][Full Text] [Related]
9. The androgen receptor gene GGN microsatellite and prostate cancer risk. Platz EA; Giovannucci E; Dahl DM; Krithivas K; Hennekens CH; Brown M; Stampfer MJ; Kantoff PW Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):379-84. PubMed ID: 9610786 [TBL] [Abstract][Full Text] [Related]
10. In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors. Tsujimoto Y; Takakuwa T; Takayama H; Nishimura K; Okuyama A; Aozasa K; Nonomura N Prostate; 2004 Feb; 58(3):283-90. PubMed ID: 14743468 [TBL] [Abstract][Full Text] [Related]
11. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk. Bratt O; Borg A; Kristoffersson U; Lundgren R; Zhang QX; Olsson H Br J Cancer; 1999 Oct; 81(4):672-6. PubMed ID: 10574254 [TBL] [Abstract][Full Text] [Related]
12. Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene. Li C; Grönberg H; Matsuyama H; Weber G; Nordenskjöld M; Naito K; Bergh A; Bergerheim U; Damber JE; Larsson C; Ekman P Int J Mol Med; 2003 Apr; 11(4):529-33. PubMed ID: 12632109 [TBL] [Abstract][Full Text] [Related]
14. Effect of a short CAG (glutamine) repeat on human androgen receptor function. Ding D; Xu L; Menon M; Reddy GP; Barrack ER Prostate; 2004 Jan; 58(1):23-32. PubMed ID: 14673949 [TBL] [Abstract][Full Text] [Related]
15. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905 [TBL] [Abstract][Full Text] [Related]
16. CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer. Shimbo M; Suzuki H; Kamiya N; Imamoto T; Komiya A; Ueda T; Watanabe M; Shiraishi T; Ichikawa T Eur Urol; 2005 Apr; 47(4):557-63. PubMed ID: 15774258 [TBL] [Abstract][Full Text] [Related]
17. Polymorphic repeats in the androgen receptor gene in high-risk sibships. Miller EA; Stanford JL; Hsu L; Noonan E; Ostrander EA Prostate; 2001 Aug; 48(3):200-5. PubMed ID: 11494335 [TBL] [Abstract][Full Text] [Related]
18. Androgen receptor gene mutations in hormone-refractory prostate cancer. Wallén MJ; Linja M; Kaartinen K; Schleutker J; Visakorpi T J Pathol; 1999 Dec; 189(4):559-63. PubMed ID: 10629558 [TBL] [Abstract][Full Text] [Related]
19. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk. Andersson P; Varenhorst E; Söderkvist P Eur J Cancer; 2006 Nov; 42(16):2833-7. PubMed ID: 17010601 [TBL] [Abstract][Full Text] [Related]
20. [CAG microsatellite polymorphisms of androgen receptor gene and the stage and grade of prostate cancer]. Li C; Dong J; Guan W Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):217-9. PubMed ID: 11783090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]